[go: up one dir, main page]

WO2018070441A1 - Procédé de fabrication d'une structure de cellule de culture - Google Patents

Procédé de fabrication d'une structure de cellule de culture Download PDF

Info

Publication number
WO2018070441A1
WO2018070441A1 PCT/JP2017/036866 JP2017036866W WO2018070441A1 WO 2018070441 A1 WO2018070441 A1 WO 2018070441A1 JP 2017036866 W JP2017036866 W JP 2017036866W WO 2018070441 A1 WO2018070441 A1 WO 2018070441A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell
cell sheet
sheet laminate
fiber
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2017/036866
Other languages
English (en)
Japanese (ja)
Inventor
正迪 井手
智亮 中西
省吾 小寺
近藤　聡
田畑　泰彦
山下　潤
謙二 南方
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Publication of WO2018070441A1 publication Critical patent/WO2018070441A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin

Definitions

  • the present invention relates to a method for producing a cultured cell structure.
  • An object of the present invention is to provide a production method for efficiently obtaining a three-dimensional structure of cultured cells by culturing stacked cell sheets.
  • a cell sheet laminate in which two or more cell sheets are laminated on a cell placement part surface of a substrate placed in a container containing a liquid medium; and on the cell placement part of the substrate
  • the cell sheet laminate is cultured in a liquid medium, and the substrate has a recess on the back surface of the cell mounting portion, and the substrate has the cell mounting portion facing the recess.
  • a method for producing a cultured cell structure comprising at least one fiber penetrating, and culturing the cell sheet laminate in a state in which the fiber extends in the lamination direction.
  • the present invention it is possible to provide a production method for efficiently obtaining a three-dimensional structure of cultured cells by culturing stacked cell sheets.
  • FIG. 1 It is a schematic sectional drawing which shows typically an example of the cultivation method of the cell sheet laminated body which concerns on this embodiment. It is a figure which shows the expression level of the cell proliferation marker in a cultured cell structure. It is a figure which shows the expression level of the cell respiration marker in a cultured cell structure. It is a figure which shows the expression level of the cell respiration marker in a cultured cell structure. It is a figure which shows an example of the image which immunostained the hypoxia marker in the cultured cell structure which concerns on Example 1. FIG. It is a figure which shows an example of the image which immunostained the hypoxia marker in the cultured cell structure which concerns on the comparative example 1. FIG.
  • FIG. 1 It is a figure which shows an example of the image which immunostained the cell proliferation marker in the cultured cell structure which concerns on Example 1.
  • FIG. It is a figure which shows an example of the image which immunostained the cell proliferation marker in the cultured cell structure which concerns on the comparative example 1.
  • FIG. It is a figure which shows an example of the image which immunostained the cell respiration marker in the cultured cell structure which concerns on Example 1.
  • FIG. It is a figure which shows an example of the image which immunostained the cell respiration marker in the cultured cell structure which concerns on the comparative example 1.
  • FIG. It is a figure which shows the expression level of the cell respiration marker in the cultured cell structure in connection with the comparative example 2, Example 5, and Example 6.
  • a cell sheet laminate in which two or more cell sheets are laminated is placed on the surface of a cell placement portion of a substrate placed in a container that contains a liquid medium. And culturing the cell sheet laminate on the cell placement part of the base material in a liquid medium, the base material has a recess on the back surface of the cell placement part, and the base material is The cell sheet laminate is cultivated with at least one fiber penetrating the cell placement portion toward the recess, and the fiber extends in the stacking direction.
  • the cell sheet laminate By culturing the cell sheet laminate on a substrate placed in a liquid medium with fibers, the cell sheet laminate can be efficiently cultured, and a three-dimensional cultured cell comprising cultured cells A structure can be manufactured efficiently.
  • a cell sheet laminate in which two or more cell sheets are laminated is placed on the surface of a cell placement portion of a substrate placed in a container that contains a liquid medium.
  • the size, shape, and material of the container for storing the liquid medium are not particularly limited as long as the liquid medium and the substrate can be disposed.
  • Examples of the container include a polystyrene petri dish having a diameter of 3.5 to 15 cm, a 6-well plate, and the like.
  • the liquid medium is prepared using a medium selected according to the cell type constituting the cell sheet laminate to be cultured as a basal medium.
  • a basal medium for example, IMDM medium, Medium 199 medium, Eagle's Minimum Essential Medium (EMEM) medium, ⁇ MEM medium, Dolbecco's modified Eagle's Medium (DMEM) medium, Ham's F16h medium, RP 's medium and mixed medium thereof can be mentioned.
  • Serum may be contained in the liquid medium.
  • the liquid medium may be, for example, albumin, transferrin, sodium selenite, ITS-X (Invitrogen) (containing insulin, transferrin, sodium selenite), Knockout Serum Replacement (KSR) (when ES cells are cultured).
  • FBS serum replacement N2 supplement (Invitrogen), B27 supplement (Invitrogen), fatty acid, insulin, collagen precursor, trace element, 2-mercaptoethanol, 3'-thiolglycerol, etc. May be included.
  • lipids lipids, essential amino acids, L-glutamine, Glutamax, non-essential amino acids, vitamins, growth factors, low molecular compounds, antibiotics, antioxidants, pyruvate, buffers, inorganic salts, etc.
  • An additive may be included.
  • the base material on which the cell sheet laminate is placed has at least a cell placement portion, and has a recess on the back surface of the cell placement portion.
  • the shape of the cell placement portion include a rectangular shape, a polygonal shape such as a triangular shape, a substantially circular shape, and an elliptical shape. What is necessary is just to select the magnitude
  • the size of the cell placement portion is 0.5 cm or more in diameter, and preferably 1 cm or more. Moreover, it is 10 cm or less, Preferably it is 5 cm or less.
  • the thickness of the base material that is, the height in the direction perpendicular to the surface of the cell placement portion is appropriately selected according to the height of the container and the like, for example, 0.1 mm or more and 20 mm or less, preferably 1 mm or more and 15 mm or less. is there.
  • the back surface of the cell placement portion of the base material may have a wall portion that forms a recess together with the back surface of the cell placement portion.
  • the end portion of the wall portion opposite to the cell placement portion may be in contact with the bottom surface of the inner wall of the container or may be spaced apart. It is preferable that at least a part of the end portion of the wall portion of the base material is in contact with the bottom surface of the inner wall of the container.
  • the size of the concave portion is, for example, 0.1 cm to 10 cm, and preferably 1 cm to 5 cm, as the height of the wall portion forming the concave portion.
  • the wall thickness is, for example, 0.1 mm to 5 mm, preferably 1 mm to 2 mm.
  • the base material examples include polystyrene (PS), polyethylene (PE), polyethylene terephthalate (PET), nylon, polytetrafluoroethylene (PTFE), ethylene-tetrafluoroethylene copolymer (ETFE), and tetrafluoroethylene- Examples thereof include hexafluoropropylene copolymer (FEP), tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (PFA), polydimethylsiloxane (PDMS), and the like.
  • PS polystyrene
  • PE polyethylene
  • PET polyethylene terephthalate
  • nylon nylon
  • PTFE polytetrafluoroethylene
  • ETFE ethylene-tetrafluoroethylene copolymer
  • tetrafluoroethylene- Examples thereof include hexafluoropropylene copolymer (FEP), tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (PFA
  • the cell placement part of the substrate has permeability to gas or liquid.
  • the cell placement part is made of a material selected from a porous material, a material having a mesh structure, and a material having a swelling property with respect to a liquid (preferably water). Preferably it is formed.
  • the permeability is, for example, 10 pmol/s/cm 2 or more with respect to air, 600pmol / s / cm 2 or more.
  • the cell placement part has swelling property with respect to the liquid or has a communicating hole, particularly excellent liquid permeability can be expected.
  • the base material is placed in the container, for example, in the container so that the surface of the cell placement portion and the bottom surface of the inner wall of the container are substantially parallel.
  • the cell placement surface of the substrate is located in the liquid medium, and the distance from the bottom surface of the inner wall of the container to the surface of the liquid culture medium is from the bottom surface of the inner wall of the container to the surface of the cell placement portion of the substrate.
  • the base material is arranged such that the distance ratio is, for example, 0.1 or more and 0.95 or less, preferably 0.5 or more and 0.95 or less.
  • Cell sheet laminated body A cell sheet laminated body is mounted on the cell mounting part surface of a base material.
  • a cell sheet laminate prepared in advance may be placed on the cell placement part surface, and the cell is placed on the cell placement part surface. You may mount by laminating
  • the cell sheet laminate is produced by laminating the cell sheets on the carrier substrate, and the cell sheet laminate is placed on the cell placement portion surface together with the carrier substrate.
  • the conveyance base material needs to be formed of at least a material having gas permeability, and more preferably formed of a material having gas permeability to a liquid in which the gas is dissolved.
  • Specific examples of the substrate for conveyance include a porous film (hereinafter referred to as a VECELL film) constituting the bottom surface of VECELL Preset (trade name, manufactured by Bethel).
  • the cell sheet laminate can be prepared by laminating two or more cell sheets.
  • Examples of the method for laminating cell sheets include a method of laminating two or more cell sheets in a liquid medium and then removing the liquid medium.
  • At least one inter-sheet fiber may be disposed between the cell sheets of the cell sheet laminate.
  • the inter-sheet fibers are arranged such that the length direction thereof is parallel to the surface of the cell sheet.
  • the at least one edge part of the fiber between sheets is located in the exterior of a cell sheet laminated body, ie, in a liquid culture medium.
  • at least one end of the inter-sheet fibers may be outside the liquid medium.
  • inter-sheet fibers are arranged between cell sheets, it is preferable to arrange one or more inter-sheet fibers per cell sheet, for example. Moreover, it can be 1 to 10 per 1 cm 2 of the cell sheet area.
  • the number of cell sheets constituting the cell sheet laminate is, for example, 2 or more and 100 or less, and preferably 2 or more and 50 or less.
  • the thickness in the stacking direction of the cell sheet laminate is, for example, 20 ⁇ m or more, preferably 500 ⁇ m or more, for example, 10 mm or less, preferably 8 mm or less.
  • the area of the surface perpendicular to the stacking direction of the cell sheet laminate is, for example, 0.15 cm 2 or more, preferably 7 cm 2 or more, and 80 cm 2 or less, preferably 10 cm 2 or less.
  • the cell sheet constituting the cell sheet laminate is a sheet-like cell aggregate composed of one layer formed by adhering a plurality of cells.
  • the cells constituting the cell sheet are not particularly limited and can be appropriately selected depending on the purpose and the like.
  • the cells constituting the cell sheet are mammalian cells including humans, and examples include somatic cells, precursor cells thereof, and mixed cells thereof.
  • Specific cells include endothelial cells, mesenchymal stem cells, adipose-derived stem cells, cord blood-derived stem cells, dental pulp stem cells, cardiomyocytes, heart wall cells, hepatocytes, fibroblasts, osteoblasts, vascular endothelial cells, liver
  • Examples include progenitor cells, mesenchymal cells, islet cells, chondrocytes, epithelial cells, and the like, and at least one cell selected from the group consisting of these is preferred.
  • the cells constituting the cell sheet may be cells contained in a tissue isolated by an arbitrary method, or may be a cell line established from the tissue.
  • cells derived from pluripotent stem cells by any method may be used.
  • the guidance method used at this time can be a method well known to those skilled in the art, and is not particularly limited.
  • the cell sheet can be produced by culturing desired cells in a sheet form in a culture device and taking out the cells in a sheet state.
  • a method for taking out the cultured cells in a sheet state for example, after culturing the cells using a culture device coated with a temperature-responsive polymer to form a cell sheet, the cell sheet is removed from the culture device by changing the temperature.
  • the method of peeling can be mentioned.
  • the temperature-responsive polymer include (meth) acrylamide compounds, N- (or N, N-di) alkyl-substituted (meth) acrylamide derivatives (see, for example, JP 2010-255001 A), or vinyl ether derivative polymers. Can be mentioned.
  • a culture device fixed with poly-N-isopropylacrylamide is exemplified.
  • Such culture equipment can also be purchased from Cellseed as UpCell.
  • a culture device coated with a temperature-responsive coating agent a culture device coated with methyl cellulose described in Chen CH, et al, Biomacromolecules. 7: 736-43, 2006, Takamoto Y, et al, A culture apparatus having a polyethylene terephthalate (PET) film coated with a block copolymer of 2-ethoxyethyl vinyl ether and 2-phenoxyethyl vinyl ether described in J. Biomater. Sci. Polymer Edn, 18: 1211-1222, 2007 Illustrated.
  • PET polyethylene terephthalate
  • the cell sheet laminate placed on the cell placement part of the substrate is cultured in a liquid medium.
  • oxygen and the like are sufficiently supplied to the inside of the cell sheet laminate, and the cell culture is in good condition Done in Thereby, for example, cell adhesion and the like proceed between the cell sheets to form a cultured cell structure that can integrally exert a physiological function.
  • the culture temperature is, for example, about 30 to 40 ° C, preferably about 37 ° C.
  • the culture is performed, for example, in an atmosphere of CO 2 -containing air, and the CO 2 concentration is, for example, 2 to 5%.
  • the culture time is, for example, 1 day to 10 days.
  • Culturing may be performed in a state where air is retained in the recess of the substrate.
  • the cell placement part of the base material is permeable to gas
  • the bottom surface of the cell sheet laminate is also adhered and cultured in the culture solution.
  • the effect that it becomes possible to culture in a state close to the gas-liquid interface is obtained.
  • At least a part of the air held in the recess may be exchanged between the start of culture and the end of culture.
  • the exchange amount can be appropriately selected according to the purpose or the like.
  • a method for exchanging air held in the recess for example, a method of supplying / recovering air through a hollow gas exchange member having one opening in the recess can be cited.
  • the air supplied to the recess may be released into the liquid medium from the cell mounting portion having gas permeability, and at least a part of the air may be recovered from the recess via the air exchange member.
  • the air retained in the recess may contain a component that gives a stimulus to the cultured cells.
  • components that stimulate cultured cells include nitric oxide, nitrogen, carbon monoxide, carbon dioxide, hydrogen hydrogen sulfide, oxygen, and the like.
  • the concentration can be appropriately selected according to the nature, purpose, and the like of the component.
  • Culturing may be performed in a state where the liquid medium is held in the recess of the base material.
  • the liquid medium held in the recess may be the same as or different from the liquid medium stored in the container.
  • the cell placement part of the base material is permeable to liquid, by culturing while holding the liquid medium in the recess, the cell sheet laminate can also be cultured from the bottom of the cell sheet while adhering culture in the liquid medium. The effect that the supply of nutrients and oxygen through a liquid medium becomes possible is obtained.
  • At least a part of the liquid medium held in the recess may be exchanged between the start of culture and the end of culture. When exchanging the liquid culture medium held in the recess, the exchange amount can be appropriately selected according to the purpose or the like.
  • a method of exchanging the liquid medium held in the recess for example, a method of supplying and recovering the liquid medium via a hollow liquid exchange member having one opening in the recess, or via a porous liquid exchange member And a method of exchanging the liquid medium.
  • the liquid medium supplied to the recess through the hollow liquid exchange member may be discharged into the liquid medium from the cell mounting portion having liquid permeability, and at least a part of the liquid medium from the recess through the liquid exchange member. It may be recovered.
  • a porous liquid exchange member is used, the liquid medium may be exchanged by diffusion.
  • the liquid medium held in the recess may contain a component that stimulates the cultured cells.
  • components that stimulate cultured cells include growth factors such as VEGF (Vascular endothelial growth factor) and bFGF (basic fibroblast growth factor), nitrogen monoxide, nitrogen, carbon monoxide, carbon dioxide, hydrogen, hydrogen sulfide, Examples thereof include oxygen.
  • VEGF Vascular endothelial growth factor
  • bFGF basic fibroblast growth factor
  • nitrogen monoxide nitrogen, carbon monoxide, carbon dioxide
  • hydrogen hydrogen sulfide
  • oxygen oxygen
  • the base material on which the cell sheet laminate is placed includes at least one fiber (filament) having one end penetrating into the cell placement portion and extending in the stacking direction of the cell sheet laminate.
  • the fiber penetrates the cell placement portion toward the recess provided on the back surface of the cell placement portion.
  • the fiber extended in the lamination direction of a cell sheet laminated body may be in contact with the cell sheet laminated body, and may penetrate the cell sheet laminated body. It is preferable that at least one of the fibers penetrates the cell sheet laminate. In particular, it is preferable that a plurality of fibers are arranged and most of the number of the fibers penetrates the cell sheet laminate.
  • the number of non-penetrating fibers may be larger than the number of fibers that penetrate, and it consists only of fibers that do not penetrate the cell sheet laminate. May be.
  • the fiber material examples include ethylene-tetrafluoroethylene copolymer (ETFE), tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (FEP), CYTOP (trade name, manufactured by Asahi Glass Co., Ltd.), and Flemion (trade name, Asahi Glass).
  • Teflon AF1600 trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.
  • Teflon AF2400 trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.
  • PDMS polydimethylsiloxane
  • the material is capable of supplying a medium.
  • a fiber swells with a culture medium. When it swells, the supply of oxygen is improved along with the medium.
  • the fiber structure may be any of a porous body, a hollow body, a solid body, and the like. From the viewpoint of exchanging liquid or gas with the concave portion, a porous body or a hollow body is preferable.
  • the fiber is a porous body or a hollow body, the liquid or gas can be easily exchanged. That is, the fiber provided in the base material may serve as the gas exchange member or the liquid exchange member.
  • the thickness of the fiber is, for example, 0.1 ⁇ m or more and 5000 ⁇ m or less as a diameter, preferably 1 ⁇ m or more and 1000 ⁇ m or less, and more preferably 10 ⁇ m or more and 500 ⁇ m or less.
  • the diameter of the hollow portion is, for example, not less than 0.1 ⁇ m and not more than 5000 ⁇ m, preferably not less than 10 ⁇ m and not more than 500 ⁇ m.
  • the length of a fiber will not be specifically limited if it is longer than the thickness of a cell sheet laminated body, For example, they are 2 mm or more and 50 mm or less, Preferably they are 5 mm or more and 30 mm or less.
  • the number of fibers is, for example, from 0.01 to 1000, preferably from 0.1 to 100, and more preferably from 0.1 to 50, per 1 cm 2 of the cell sheet area.
  • the ratio of the number of fibers penetrating the cell sheet laminate to the total number of fibers provided in the substrate is preferably 50% to 100%, more preferably 80% to 100%.
  • FIG. 1 is a schematic cross-sectional view schematically showing an example of a method for culturing a cell sheet laminate according to the present embodiment.
  • the liquid medium 16 is accommodated in the container 2, and the base material 4 is disposed inside the container 2.
  • a cell sheet laminate 14 is placed on the surface of the cell placement portion 6 of the base 4 via a transport base 12.
  • the cell sheet laminated body 14 may be directly mounted on the surface of the cell mounting part 6 without using the conveyance base material 12.
  • a recess 8 is formed on the back surface of the cell placement unit 6, and a liquid medium 16 is held in the recess 8. Air may be held in the recess 8 instead of the liquid medium 16.
  • the cell sheet laminate placed on the surface of the cell placement unit 6 is cultured at a position closer to the surface of the liquid medium than placed on the bottom surface 18 of the inner wall of the container.
  • the base material 4 is provided with the fiber 10 which penetrates the cell mounting part 6 toward the recessed part 8, and the fiber 10 penetrates the cell sheet laminated body 14, and is extended in the lamination direction of the cell sheet laminated body 14. Yes.
  • the fiber 10 penetrates the cell sheet laminate 14 in the lamination direction, but may contact the side surface of the cell sheet laminate 14 without penetrating the cell sheet laminate 14.
  • one end of the fiber 10 is located in the recess 8 and the other end is located in the liquid medium, but the other end may be located outside the liquid medium 16. .
  • the cultured cell structure produced by the production method of the present embodiment has a feature of maintaining high cell activity while having a thickness that causes necrosis inside the conventional culture method, such as drug discovery research and regenerative medicine. It can be applied to any use.
  • the cultured cell structure was evaluated by immunostaining and Western blot analysis as described below.
  • Immunostaining The obtained cultured cell structure was washed twice with phosphate buffered saline (PBS), fixed with 4% paraformaldehyde, solidified with OCT compound, sliced into 10 ⁇ m thickness with a cryostat, and frozen section. Was made. The frozen section was prepared so that a cross section parallel to the stacking direction could be observed. Immunostaining includes hypoxia probe (Hypoxyprobe), a hypoxia marker, pyruvate dehydrogenase (PDH) antibody (SANTA CRUZ BIOTECHNOLOGY), a cell respiration marker, Ki-67 antibody (Santa TA), a cell proliferation marker. BIOTECHNOLOGY). Images of immunostained cultured cell structures are shown in FIGS.
  • PBS phosphate buffered saline
  • the PVdF membrane was washed with TBST (Tris Buffered Saline with Tween 20), and then treated with an HRP (horseradish peroxidase) -conjugated secondary antibody. After the treatment for a predetermined time, it was washed again with TBST, treated with SuperSignal Chemiluminescent Substrate (Thermo scientific), and visualized using LAS4000 (trade name, manufactured by Fuji Film). The obtained image was subjected to relative quantification using image analysis software Image J. The evaluation results are shown in FIGS.
  • a cell culture polystyrene 6-well plate is seeded with 2 mL of a medium in a human mesenchymal stem cell line (hMSC) to 200,000 cells / well, and cultured for 8 to 10 days while changing the medium every 3 days. A cell sheet was formed on the plate.
  • hMSC human mesenchymal stem cell line
  • Preparation of cell sheet laminate A 10 cm cell culture PS petri dish was treated with a 0.1% gelatin aqueous solution at room temperature for 10 minutes.
  • the cell sheet formed as described above was peeled off by pipetting, and the peeled cell sheet was sucked with a decantation or pipette tip having a large diameter and transferred to a gelatin-coated PS petri dish.
  • the medium was dripped with a pipette to stretch the cell sheet wrinkles.
  • the dropped medium was sucked off and allowed to stand in an incubator at 37 ° C. and 5% CO 2 for 30 minutes to adhere the cell sheet to the petri dish.
  • the next cell sheet is transferred to a petri dish together with the culture medium, stacked on the adhered cell sheet, and after dropping the culture medium with a pipette to stretch the cell sheet wrinkles, the culture medium is sucked off, and the medium is sucked at 37 ° C, 5% CO 2. In the incubator for 30 minutes to laminate the cell sheets.
  • the cell sheet lamination operation was repeated a predetermined number of times to obtain a cell sheet laminate in which a predetermined number of cell sheets were laminated.
  • a VECELL film was used as a transport substrate, and the laminate peeled off from the PS petri dish with a spatula or the like was adsorbed to the VECELL film and transferred to the placement section.
  • the medium was poured directly into the laminate and cultured.
  • the stacked body in which 3 to 10 sheets are stacked is transported onto another stacked body using a VECELL film, and the stacked body is peeled off. It can also be produced by sequentially laminating each other.
  • Example 1 A cell sheet laminate comprising 5 cell sheets was placed on the bottom of the inner wall of a 10 cm cell culture PS petri dish, and 10 mL of MEM- ⁇ medium (10% fetal bovine serum, 1% penicillin / streptomycin) was added. Culturing was performed for a predetermined period in an incubator at 37 ° C. and 5% CO 2 . The cultured cell structure obtained after the culture was evaluated by immunostaining by the frozen section method and Western blot analysis. Images obtained by immunostaining the hypoxia marker, cell proliferation marker and cell respiration marker are shown in FIGS. 6, 8 and 10, respectively. The results of Western blot analysis are shown in FIGS.
  • Example 1 CYTOP CTL-109S (trade name, manufactured by Asahi Glass Co., Ltd.) was coated on the outer surface of a syringe needle having an inner diameter of 400 ⁇ m to produce a hollow filament having a wall thickness of about 30 ⁇ m.
  • the SEM image of the produced hollow filament is shown in FIG.
  • the left figure of FIG. 12 is an image with a magnification of 100 times, and the right figure is an image with a magnification of 1000 times.
  • the hollow filament is penetrated through the cell sheet laminate, the VECELL membrane and the dish bottom together with the syringe needle, and the filament
  • the syringe needle was pulled out while pressing with tweezers.
  • the remaining filament was in a state where one end was in the dish and the other end was exposed to the air from the medium surface.
  • the cell sheet was the same as Comparative Example 2 except that the filaments were arranged in a state of penetrating the cell sheet laminate at a rate of 2 per 0.8 cm 2 and that the number of laminated cell sheets was 5.
  • Laminates were cultured and evaluated by immunostaining by Western section and Western blot analysis. The evaluation results are shown in FIGS. Moreover, the image which immunostained the hypoxia marker, the cell proliferation marker, and the cell respiration marker is shown in FIG.5, FIG.7 and FIG.9, respectively.
  • Example 2 The cell sheet laminate was cultured and evaluated in the same manner as in Example 1 except that Teflon AF1600 (trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.) was used instead of CYTOP CTL-109S. Results similar to 1 were obtained.
  • Teflon AF1600 trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.
  • CYTOP CTL-109S was coated on the outer surface of a syringe needle having an inner diameter of 400 ⁇ m to produce a hollow filament. After placing the cell sheet laminate formed on the VECELL membrane on the bottom of the dish, the hollow filament is passed through the cell sheet laminate, the VECELL membrane and the bottom of the dish together with the syringe needle, and the syringe needle while pressing the filament with tweezers Pulled out. The remaining filament was in a state where one end was in the dish and the other end was exposed to the air from the medium surface.
  • the cell sheet laminate was cultured in the same manner as in Example 1 except that only one filament was disposed so as to penetrate the center of the cell sheet laminate.
  • the cell sheet laminate was punched out to 5 mm ⁇ centering on the position where the fiber penetrated, and the expression level of PDH as a cell respiration marker was evaluated in the same manner as in Example 1.
  • the evaluation results are shown in FIG.
  • the vertical axis in FIG. 4 is the PDH expression level corrected with the actin expression level.
  • Example 3 The cell sheet laminate was cultured and evaluated in the same manner as in Example 3 except that only one 400 ⁇ m diameter syringe needle was used instead of the filament so as to penetrate the center of the cell sheet laminate. The evaluation results are shown in FIG.
  • FIG. 4 shows that the amount of PDH expressed was higher in Example 3 using fibers than in Comparative Example 3 using syringe needles. In the one-sided test, a significant difference was recognized at a significance level of 5%.
  • Example 4 When the cell sheet laminate was cultured and evaluated in the same manner as in Example 3 except that Teflon AF1600 was used instead of CYTOP CTL-109S, the same results as in Example 3 were obtained.
  • FIG. 13 shows an SEM image of the produced hollow filament.
  • the left figure of FIG. 13 is an image with a magnification of 100 times, and the right figure is an image with a magnification of 1000 times. The evaluation results are shown in FIG.
  • Example 6 Flemion EW909 was used in place of CYTOP CTL-109S, a gelatin film was precoated as a sacrificial layer on the outer surface of the syringe needle, and Flemion was annealed in an oven at 120 ° C. for 10 minutes at a rate of 3 per 1.76 cm 2.
  • the cell sheet laminate was cultured and evaluated by Western blot analysis in the same manner as in Comparative Example 2 except that the filament was disposed in a state of penetrating the cell sheet laminate. The evaluation results are shown in FIG. It can be seen from FIG. 11 that Comparative Example 2 using no fiber showed significantly higher PDH expression in Examples 5 and 6 using fiber. Moreover, the tendency for the PDH expression level to become higher is seen when the number of fibers is three than one.
  • Example 7 A hollow filament was prepared by coating gelatin hydrogel on the outer surface of a syringe needle having an inner diameter of 400 ⁇ m and thermally crosslinking in a vacuum oven at 140 ° C. for 72 hours.
  • the cell sheet laminate was cultured and evaluated in the same manner as in Example 3 except that a crosslinked gelatin hydrogel was used instead of CYTOP CTL-109S, and the same results as in Example 3 were obtained. .
  • Example 8 Flemion EW909 was used instead of CYTOP CTL-109S, a gelatin film was precoated as a sacrificial layer on the outer surface of the syringe needle, Flemion EW909 was annealed in an oven at 120 ° C. for 10 minutes, and between the cell sheets.
  • a cell sheet laminate was cultured in the same manner as in Example 3 except that 45 sheets were laminated by sandwiching gelatin hydrogel particles having a particle diameter of 20 ⁇ m to 32 ⁇ m by the method described in 1. After culturing for a predetermined period and examining whether the cell sheet laminate was stably held on the substrate, the laminate was stably held on the substrate even after culturing for 2 days or more.
  • Example 4 A cell sheet laminate in which gelatin hydrogel particles having a particle diameter of 20 ⁇ m to 32 ⁇ m were sandwiched between the cell sheets by the method described in Patent Document 2 and 45 cell sheets were stacked was not disposed in the dish.
  • the cell sheet laminate was cultured in the same manner as in Example 1 except that it was placed on the bottom of the inner wall, and it was examined whether the cell sheet laminate was stably cultured on a petri dish. As a result, on the second day of culture, the cell sheet laminate peeled from the petri dish and contracted, or peeled between the sheets and fell apart. It should be noted that the entire content of the specification, claims, drawings and abstract of Japanese Patent Application No. 2016-200864 filed on October 12, 2016 is cited herein as the disclosure of the specification of the present invention. Incorporated.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L'invention concerne un procédé de production permettant d'obtenir efficacement une structure tridimensionnelle d'une cellule de culture par culture d'une feuille de cellules stratifiée. Ce procédé de production d'une structure de cellule de culture comprend : le positionnement d'une feuille de cellules stratifiée, deux feuilles de cellules ou plus étant stratifiées, sur la surface d'une partie de positionnement de cellules d'un substrat disposé dans un récipient destiné à recevoir un milieu de culture liquide ; et la culture, dans le milieu de culture liquide, de la feuille de cellules stratifiée qui se trouve sur la partie de positionnement de cellules du substrat, le substrat ayant une partie de renfoncement dans la surface arrière de la partie de positionnement de cellules, et étant pourvu d'au moins une fibre traversant la partie de positionnement de cellules dans la direction de la partie de renfoncement, et la feuille de cellules stratifiée étant cultivée tandis que la fibre correspondante s'étend dans la direction de stratification.
PCT/JP2017/036866 2016-10-12 2017-10-11 Procédé de fabrication d'une structure de cellule de culture Ceased WO2018070441A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016200864A JP2019213457A (ja) 2016-10-12 2016-10-12 培養細胞構造体の製造方法
JP2016-200864 2016-10-12

Publications (1)

Publication Number Publication Date
WO2018070441A1 true WO2018070441A1 (fr) 2018-04-19

Family

ID=61905313

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/036866 Ceased WO2018070441A1 (fr) 2016-10-12 2017-10-11 Procédé de fabrication d'une structure de cellule de culture

Country Status (2)

Country Link
JP (1) JP2019213457A (fr)
WO (1) WO2018070441A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008123614A1 (fr) * 2007-03-30 2008-10-16 Kyushu University, National University Corporation Procédé de production de structure tridimensionnelle de cellules
WO2014192909A1 (fr) * 2013-05-31 2014-12-04 ｉＨｅａｒｔ Ｊａｐａｎ株式会社 Plaque de cellules stratifiée comprenant un hydrogel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008123614A1 (fr) * 2007-03-30 2008-10-16 Kyushu University, National University Corporation Procédé de production de structure tridimensionnelle de cellules
WO2014192909A1 (fr) * 2013-05-31 2014-12-04 ｉＨｅａｒｔ Ｊａｐａｎ株式会社 Plaque de cellules stratifiée comprenant un hydrogel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHIMIZU: "Cell Sheet-Based Tissue Engineering for Fabricating 3-Dimentional Heart Tissues", CIRCULATION JOURNAL, vol. 78, 2014, pages 2594 - 2603, XP055476194 *

Also Published As

Publication number Publication date
JP2019213457A (ja) 2019-12-19

Similar Documents

Publication Publication Date Title
Liu et al. Porous nanofibrous poly (L-lactic acid) scaffolds supporting cardiovascular progenitor cells for cardiac tissue engineering
JP6948261B2 (ja) 多能性幹細胞または脂肪組織もしくは骨髄由来の間葉系幹細胞由来の心筋細胞の凍結保存方法
CN107208053A (zh) 使用聚酰亚胺多孔质膜的细胞的大量培养方法、装置及试剂盒
CN108410797A (zh) 在中空纤维生物反应器中扩增干细胞
JP2016093149A (ja) 細胞培養装置および細胞培養方法
WO2016060260A1 (fr) Fragment de tissu
CN105229145A (zh) 片状细胞培养物的制造方法
JP6690001B2 (ja) 細胞組織の製造方法、及び多孔フィルム
CN107208031A (zh) 细胞的培养方法及试剂盒
JP7282232B2 (ja) 接着状態の細胞培養物の改変方法
CN107075443B (zh) 三维细胞培养系统和使用该系统的细胞培养方法
US9644177B2 (en) Extracellular matrix films and methods of making and using same
JP4220756B2 (ja) 培養器、培養器の製造方法及び培養方法
JP2015165783A (ja) 多能性幹細胞からなる細胞塊製造方法
US20240368508A1 (en) Stackable plates for culturing tissue models
US20240216440A1 (en) String-like aggregates of retinal pigment epithelial cells, device and production method for producing same, and therapeutic agent comprising said string-like aggregates
WO2018070441A1 (fr) Procédé de fabrication d'une structure de cellule de culture
JP7672796B2 (ja) スフェロイド及びその作製方法
WO2021065984A1 (fr) Procédé de formation de feuille de cardiomyocytes
JP2016013111A (ja) 底面部を剥離可能な培養容器
JP2023105226A (ja) 肝細胞培養体の製造方法、細胞入り多孔フィルム、及び肝細胞又は肝前駆細胞の機能向上又は機能維持方法
JP2017077240A (ja) 接着性細胞培養用基材、ならびにこれを利用した細胞培養容器および細胞培養方法
US20220002677A1 (en) Transfer method
CN108473930A (zh) 用于重建的组织的包括具有不同直径的孔的膜
JP2016123326A (ja) 収容構造を有する細胞構造体

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17860390

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17860390

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP